Notice Number: NOT-CA-16-069
Key Dates
Release Date: September 1, 2016
Issued by
National Cancer Institute (NCI)
Purpose
This Notice changes the Application Due Dates and other Key Dates for PAR-16-416, "NCI Small Grants Program for Cancer Research (NCI Omnibus R03)".
Currently reads:
Application Due Date(s): February 28, 2017; June 27, 2017; October 26, 2017; February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019
AIDS Application Due Date(s): May 7, 2017; September 7, 2017; January 7, 2018; May 7, 2018; September 7, 2018; January 7, 2019; May 7, 2019; September 7, 2019; January 7, 2020
Scientific Merit Review: June/July 2017; October/November 2017; February/March 2018; June/July 2018; October/November 2018; February/March 2019; June/July 2019; October/November 2019; February/March 2020
Advisory Council Review: October 2017; January 2018; May 2018; October 2018; January 2019; May 2019; October 2019; January 2020; May 2020
Earliest Start Date: December 2017; April 2018; July 2018; December 2018; April 2019; July 2019; December 2019; April 2020; July 2020
Modified to read:
Application Due Date(s): October 28, 2016; February 28, 2017; June 27, 2017; October 26, 2017; February 27, 2018; June 29, 2018; October 26, 2018; February 26, 2019; June 28, 2019; October 25, 2019
AIDS Application Due Date(s): January 5, 2017; May 7, 2017; September 7, 2017; January 7, 2018; May 7, 2018; September 7, 2018; January 7, 2019; May 7, 2019; September 7, 2019; January 7, 2020
Scientific Merit Review: February/March 2017; June/July 2017; October/November 2017; February/March 2018; June/July 2018; October/November 2018; February/March 2019; June/July 2019; October/November 2019; February/March 2020
Advisory Council Review: May 2017; October 2017; January 2018; May 2018; October 2018; January 2019; May 2019; October 2019; January 2020; May 2020
Earliest Start Date: July 2017; December 2017; April 2018; July 2018; December 2018; April 2019; July 2019; December 2019; April 2020; July 2020
All other aspects of this FOA remain unchanged.
Inquiries
Please direct all inquiries to:
Referral Officer
National Cancer Institute
Telephone: 240-276-6390
Email: [email protected]